Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, March 2000, p. 739-746, Vol. 44, No. 3
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Synergistic Antifungal Activities of Bafilomycin
A1, Fluconazole, and the Pneumocandin MK-0991/Caspofungin
Acetate (L-743,873) with Calcineurin Inhibitors FK506 and
L-685,818 against Cryptococcus neoformans
Maurizio
Del
Poeta,1,2,3
M. Cristina
Cruz,4
Maria E.
Cardenas,4
John R.
Perfect,1,5 and
Joseph
Heitman1,4,5,6,7,*
Departments of
Medicine,1
Genetics,4 Pharmacology and
Cancer Biology,6 and
Microbiology,5 Howard Hughes
Medical Institute,7 Duke University Medical
Center, Durham, North Carolina 27710; College of Medicine,
Medical University of South Carolina, Charleston, South Carolina
294252; and Institute of Infectious
Diseases and Public Health, University of Ancona, Ospedale Umberto
I, 60121 Ancona, Italy3
Received 7 September 1999/Returned for modification 16 November
1999/Accepted 20 December 1999
Cryptococcus neoformans is an opportunistic fungal
pathogen that causes life-threatening infections of the central nervous system. Existing therapies include amphotericin B, fluconazole, and
flucytosine, which are limited by toxic side effects and the emergence
of drug resistance. We recently demonstrated that the protein
phosphatase calcineurin is required for growth at 37°C and virulence
of C. neoformans. Because calcineurin is the target of
potent inhibitors in widespread clinical use, cyclosporine and FK506
(tacrolimus), it is an attractive drug target for novel antifungal
agents. Here we have explored the synergistic potential of combining
the calcineurin inhibitor FK506 or its nonimmunosuppressive analog,
L-685,818, with other antifungal agents and examined the molecular
basis of FK506 action by using genetically engineered fungal strains
that lack the FK506 target proteins FKBP12 and calcineurin. We
demonstrate that FK506 exhibits marked synergistic activity with the
H+ATPase inhibitor bafilomycin A1 via a novel
action distinct from calcineurin loss of function. FK506 also exhibits
synergistic activity with the pneumocandin MK-0991/caspofungin acetate
(formerly L-743,873), which targets the essential
-1,3 glucan
synthase, and in this case, FK506 action is mediated via
FKBP12-dependent inhibition of calcineurin. Finally, we demonstrate
that FK506 and fluconazole have synergistic activity that is
independent of both FKBP12 and calcineurin and may involve the known
ability of FK506 to inhibit multidrug resistance pumps, which are known to export azoles from fungal cells. In summary, our studies illustrate the potential for synergistic activity of a variety of different drug
combinations and the power of molecular genetics to define the
mechanisms of drug action, as well as identify a novel action of FK506
that could have profound implications for therapeutic or toxic effects
in other organisms, including humans.
*
Corresponding author. Mailing address: 322 CARL
Building, Box 3546, Research Dr., Duke University Medical Center,
Durham, NC 27710. Phone: (919) 684-2824. Fax: (919) 684-5458. E-mail: heitm001{at}duke.edu.
Antimicrobial Agents and Chemotherapy, March 2000, p. 739-746, Vol. 44, No. 3
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Dannaoui, E., Schwarz, P., Lortholary, O.
(2009). In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes. Antimicrob. Agents Chemother.
53: 3549-3551
[Abstract]
[Full Text]
-
Dudgeon, D. D., Zhang, N., Ositelu, O. O., Kim, H., Cunningham, K. W.
(2008). Nonapoptotic Death of Saccharomyces cerevisiae Cells That Is Stimulated by Hsp90 and Inhibited by Calcineurin and Cmk2 in Response to Endoplasmic Reticulum Stresses. Eukaryot Cell
7: 2037-2051
[Abstract]
[Full Text]
-
Cowen, L. E., Steinbach, W. J.
(2008). Stress, Drugs, and Evolution: the Role of Cellular Signaling in Fungal Drug Resistance. Eukaryot Cell
7: 747-764
[Full Text]
-
Sun, S., Li, Y., Guo, Q., Shi, C., Yu, J., Ma, L.
(2008). In Vitro Interactions between Tacrolimus and Azoles against Candida albicans Determined by Different Methods. Antimicrob. Agents Chemother.
52: 409-417
[Abstract]
[Full Text]
-
Kontoyiannis, D. P., Lewis, R. E., Alexander, B. D., Lortholary, O., Dromer, F., Gupta, K. L., John, G. T., del Busto, R., Klintmalm, G. B., Somani, J., Lyon, G. M., Pursell, K., Stosor, V., Munoz, P., Limaye, A. P., Kalil, A. C., Pruett, T. L., Garcia-Diaz, J., Humar, A., Houston, S., House, A. A., Wray, D., Orloff, S., Dowdy, L. A., Fisher, R. A., Heitman, J., Albert, N. D., Wagener, M. M., Singh, N.
(2008). Calcineurin Inhibitor Agents Interact Synergistically with Antifungal Agents In Vitro against Cryptococcus neoformans Isolates: Correlation with Outcome in Solid Organ Transplant Recipients with Cryptococcosis. Antimicrob. Agents Chemother.
52: 735-738
[Abstract]
[Full Text]
-
Zhang, N.-N., Dudgeon, D. D., Paliwal, S., Levchenko, A., Grote, E., Cunningham, K. W.
(2006). Multiple Signaling Pathways Regulate Yeast Cell Death during the Response to Mating Pheromones. Mol. Biol. Cell
17: 3409-3422
[Abstract]
[Full Text]
-
Kojima, K., Bahn, Y.-S., Heitman, J.
(2006). Calcineurin, Mpk1 and Hog1 MAPK pathways independently control fludioxonil antifungal sensitivity in Cryptococcus neoformans.. Microbiology
152: 591-604
[Abstract]
[Full Text]
-
Maligie, M. A., Selitrennikoff, C. P.
(2005). Cryptococcus neoformans Resistance to Echinocandins: (1,3){beta}-Glucan Synthase Activity Is Sensitive to Echinocandins. Antimicrob. Agents Chemother.
49: 2851-2856
[Abstract]
[Full Text]
-
Sugita, T., Tajima, M., Ito, T., Saito, M., Tsuboi, R., Nishikawa, A.
(2005). Antifungal Activities of Tacrolimus and Azole Agents against the Eleven Currently Accepted Malassezia Species. J. Clin. Microbiol.
43: 2824-2829
[Abstract]
[Full Text]
-
Ibrahim, A. S., Bowman, J. C., Avanessian, V., Brown, K., Spellberg, B., Edwards, J. E. Jr., Douglas, C. M.
(2005). Caspofungin Inhibits Rhizopus oryzae 1,3-{beta}-D-Glucan Synthase, Lowers Burden in Brain Measured by Quantitative PCR, and Improves Survival at a Low but Not a High Dose during Murine Disseminated Zygomycosis. Antimicrob. Agents Chemother.
49: 721-727
[Abstract]
[Full Text]
-
Steinbach, W. J., Singh, N., Miller, J. L., Benjamin, D. K. Jr., Schell, W. A., Heitman, J., Perfect, J. R.
(2004). In Vitro Interactions between Antifungals and Immunosuppressants against Aspergillus fumigatus Isolates from Transplant and Nontransplant Patients. Antimicrob. Agents Chemother.
48: 4922-4925
[Abstract]
[Full Text]
-
Cuenca-Estrella, M.
(2004). Combinations of antifungal agents in therapy-what value are they?. J Antimicrob Chemother
54: 854-869
[Abstract]
[Full Text]
-
Markovich, S., Yekutiel, A., Shalit, I., Shadkchan, Y., Osherov, N.
(2004). Genomic Approach to Identification of Mutations Affecting Caspofungin Susceptibility in Saccharomyces cerevisiae. Antimicrob. Agents Chemother.
48: 3871-3876
[Abstract]
[Full Text]
-
Pascon, R. C., Ganous, T. M., Kingsbury, J. M., Cox, G. M., McCusker, J. H.
(2004). Cryptococcus neoformans methionine synthase: expression analysis and requirement for virulence. Microbiology
150: 3013-3023
[Abstract]
[Full Text]
-
Steinbach, W. J., Schell, W. A., Blankenship, J. R., Onyewu, C., Heitman, J., Perfect, J. R.
(2004). In Vitro Interactions between Antifungals and Immunosuppressants against Aspergillus fumigatus. Antimicrob. Agents Chemother.
48: 1664-1669
[Abstract]
[Full Text]
-
Niimi, K., Harding, D. R. K., Parshot, R., King, A., Lun, D. J., Decottignies, A., Niimi, M., Lin, S., Cannon, R. D., Goffeau, A., Monk, B. C.
(2004). Chemosensitization of Fluconazole Resistance in Saccharomyces cerevisiae and Pathogenic Fungi by a D-Octapeptide Derivative. Antimicrob. Agents Chemother.
48: 1256-1271
[Abstract]
[Full Text]
-
Johnson, M. D., MacDougall, C., Ostrosky-Zeichner, L., Perfect, J. R., Rex, J. H.
(2004). Combination Antifungal Therapy. Antimicrob. Agents Chemother.
48: 693-715
[Full Text]
-
Bonilla, M., Cunningham, K. W.
(2003). Mitogen-activated Protein Kinase Stimulation of Ca2+ Signaling Is Required for Survival of Endoplasmic Reticulum Stress in Yeast. Mol. Biol. Cell
14: 4296-4305
[Abstract]
[Full Text]
-
Berthet, N., Faure, O., Bakri, A., Ambroise-Thomas, P., Grillot, R., Brugere, J.-F.
(2003). In vitro susceptibility of Aspergillus spp. clinical isolates to albendazole. J Antimicrob Chemother
51: 1419-1422
[Abstract]
[Full Text]
-
Gauthier, C., Weber, S., Alarco, A.-M., Alqawi, O., Daoud, R., Georges, E., Raymond, M.
(2003). Functional Similarities and Differences between Candida albicans Cdr1p and Cdr2p Transporters. Antimicrob. Agents Chemother.
47: 1543-1554
[Abstract]
[Full Text]
-
Kontoyiannis, D. P., Lewis, R. E., Osherov, N., Albert, N. D., May, G. S.
(2003). Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species. J Antimicrob Chemother
51: 313-316
[Abstract]
[Full Text]
-
Cruz, M. C., Goldstein, A. L., Blankenship, J., Del Poeta, M., Perfect, J. R., McCusker, J. H., Bennani, Y. L., Cardenas, M. E., Heitman, J.
(2001). Rapamycin and Less Immunosuppressive Analogs Are Toxic to Candida albicans and Cryptococcus neoformans via FKBP12-Dependent Inhibition of TOR. Antimicrob. Agents Chemother.
45: 3162-3170
[Abstract]
[Full Text]
-
Lengeler, K. B., Davidson, R. C., D'souza, C., Harashima, T., Shen, W.-C., Wang, P., Pan, X., Waugh, M., Heitman, J.
(2000). Signal Transduction Cascades Regulating Fungal Development and Virulence. Microbiol. Mol. Biol. Rev.
64: 746-785
[Abstract]
[Full Text]
-
Marchetti, O., Entenza, J. M., Sanglard, D., Bille, J., Glauser, M. P., Moreillon, P.
(2000). Fluconazole plus Cyclosporine: a Fungicidal Combination Effective against Experimental Endocarditis Due to Candida albicans. Antimicrob. Agents Chemother.
44: 2932-2938
[Abstract]
[Full Text]